Ruxolitinib (INCB018424) 10mM (in 1mL DMSO) | 99.29%
APEXBIO TECHNOLOGY LLC
Ruxolitinib (INCB018424)
Search Results
Ruxolitinib (INCB018424) Evaluation Sample | 99.29%
APEXBIO TECHNOLOGY LLC
Ruxolitinib (INCB018424)
Ruxolitinib (INCB018424) 5mg | 99.29%
APEXBIO TECHNOLOGY LLC
Ruxolitinib (INCB018424)
Ruxolitinib (INCB018424) 25mg | 99.29%
APEXBIO TECHNOLOGY LLC
Ruxolitinib (INCB018424)
Ruxolitinib (INCB018424) 100mg | 99.29%
APEXBIO TECHNOLOGY LLC
Ruxolitinib (INCB018424)
CHIR-99021 (CT99021) Evaluation Sample | 98.83%
APEXBIO TECHNOLOGY LLC
GSK-3 inhibitor, Cell-permeable, ATP-competitive PI3K/Akt/mTOR Signaling|GSK-3
More Information Supplier PageCHIR-99021 (CT99021)
CHIR-99021 (CT99021) 5mg | 98.83%
APEXBIO TECHNOLOGY LLC
GSK-3 inhibitor, Cell-permeable, ATP-competitive PI3K/Akt/mTOR Signaling|GSK-3
More Information Supplier PageCHIR-99021 (CT99021)
CHIR-99021 (CT99021) 10mg | 98.83%
APEXBIO TECHNOLOGY LLC
GSK-3 inhibitor, Cell-permeable, ATP-competitive PI3K/Akt/mTOR Signaling|GSK-3
More Information Supplier PageCHIR-99021 (CT99021)
CHIR-99021 (CT99021) 25mg | 98.83%
APEXBIO TECHNOLOGY LLC
GSK-3 inhibitor, Cell-permeable, ATP-competitive PI3K/Akt/mTOR Signaling|GSK-3
More Information Supplier PageCHIR-99021 (CT99021)
CHIR-99021 (CT99021) 100mg | 98.83%
APEXBIO TECHNOLOGY LLC
GSK-3 inhibitor, Cell-permeable, ATP-competitive PI3K/Akt/mTOR Signaling|GSK-3
More Information Supplier PageCHIR-99021 (CT99021)